<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Breathing on VitaminDWiki</title><link>//localhost:1313/categories/breathing.html</link><description>Recent content in Breathing on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Fri, 19 Apr 2024 00:00:00 +0000</lastBuildDate><atom:link href="//localhost:1313/categories/breathing/index.xml" rel="self" type="application/rss+xml"/><item><title>Major reduction allergies and asthma if the child was born in a sunny season (in Paris in this case)</title><link>//localhost:1313/posts/major-reduction-allergies-and-asthma-if-the-child-was-born-in-a-sunny-season-in-paris-in-this-case.html</link><pubDate>Fri, 19 Apr 2024 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/major-reduction-allergies-and-asthma-if-the-child-was-born-in-a-sunny-season-in-paris-in-this-case.html</guid><description>&lt;h4 id="early-exposure-to-sunlight-and-allergic-morbidity-the-paris-birth-cohort">Early exposure to sunlight and allergic morbidity: The PARIS birth cohort&lt;/h4>
&lt;p>Sci Total Environ. 2024 Apr 16:172543. &lt;a href="https://doi.org/10.1016/j.scitotenv.2024.172543">doi: 10.1016/j.scitotenv.2024.172543&lt;/a> PDF is behind a paywall&lt;/p>
&lt;p>Léa Lefebvre 1, Hélène Amazouz 2, Fanny Rancière 3, Isabelle Momas 4&lt;/p>
&lt;p>The relationship between sunlight and allergies in children has received limited attention from researchers. We sought to explore how early exposure to solar radiation is associated with allergic morbidity within the PARIS birth cohort study. Our research dealt with children who attended at least one of two health checkups: at 18 months (n = 2012) and at 8-9 years (n = 1080).&lt;/p></description></item><item><title>40 cents of Vitamin D given once during pregnancy reduced respiratory problems by 3%</title><link>//localhost:1313/posts/40-cents-of-vitamin-d-given-once-during-pregnancy-reduced-respiratory-problems-by-3-percent.html</link><pubDate>Wed, 28 Feb 2024 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/40-cents-of-vitamin-d-given-once-during-pregnancy-reduced-respiratory-problems-by-3-percent.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-of-maternal-gestational-vitamin-d-supplementation-with-respiratory-health-of-young-children">Association of Maternal Gestational Vitamin D Supplementation with Respiratory Health of Young Children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dosing-at-the-7th-month-week-28-provides-no-benefit-in-weeks-0-28">Dosing at the 7th month (week 28) provides no benefit in weeks 0-28&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-of-maternal-gestational-vitamin-d-supplementation-with-respiratory-health-of-young-children">Association of Maternal Gestational Vitamin D Supplementation with Respiratory Health of Young Children&lt;/h4>
&lt;p>Nutrients Volume 15 Issue 10 10.3390/nu15102380&lt;/p>
&lt;p>by Fanny Loddo 1,Steve Nauleau 2,David Lapalus 2,Sophie Tardieu 3,Olivier Bernard 2 andFarid Boubred 1,4,*&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1 APHM, Neonatal Unit, Hospital University la Conception, 13005 Marseille, France&lt;/p></description></item><item><title>Vitamin D levels are low during Recurrent Wheezing</title><link>//localhost:1313/posts/vitamin-d-levels-are-low-during-recurrent-wheezing.html</link><pubDate>Sat, 24 Feb 2024 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/vitamin-d-levels-are-low-during-recurrent-wheezing.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-level-and-immune-modulation-in-children-with-recurrent-wheezing">Vitamin D Level and Immune Modulation in Children with Recurrent Wheezing&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-level-and-immune-modulation-in-children-with-recurrent-wheezing">Vitamin D Level and Immune Modulation in Children with Recurrent Wheezing&lt;/h4>
&lt;p>Children 2024, 11(2), 219; &lt;a href="https://doi.org/10.3390/children11020219">https://doi.org/10.3390/children11020219&lt;/a>&lt;/p>
&lt;p>by Gavriela Feketea 1,2ORCID,Emilia Vassilopoulou 3,*ORCID,Oana Andreescu 4,Elena Camelia Berghea 5,6ORCID,Raluca Maria Pop 1ORCID,Octavia Sabin 1ORCID,Mihnea Zdrenghea 7,8ORCID andIoana Corina Bocsan 1ORCID&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/recurrent-wheezing.png" alt="image" width="350">
&lt;p>Introduction and aim: A direct causal relationship between vitamin D (vit D) deficiency and recurrent wheezing has not been proven. The present study investigated the role of vit D in enhancing the risk of asthma or recurrent wheezing by modifying the intensity of the inflammatory process. Material and method: Forty children with wheezing presenting at the emergency service and sixteen healthy control subjects were included in the study. Children with wheezing were either in the first episode (20) or with recurrent wheezing (20).&lt;/p></description></item><item><title>Obese asthmatic children Vitamin D - 50,000 IU then 8,000 IU daily - RCT</title><link>//localhost:1313/posts/obese-asthmatic-children-vitamin-d-50000-iu-then-8000-iu-daily-rct.html</link><pubDate>Wed, 24 Jan 2024 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/obese-asthmatic-children-vitamin-d-50000-iu-then-8000-iu-daily-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-oral-replacement-in-children-with-obesity-related-asthma-vdora1-randomized-clinical-trial">Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-oral-replacement-in-children-with-obesity-related-asthma-vdora1-randomized-clinical-trial">Vitamin D Oral Replacement in Children With Obesity Related Asthma: VDORA1 Randomized Clinical Trial&lt;/h4>
&lt;p>Clin Pharmacol Ther 2024 Feb;115(2):231-238. &lt;a href="https://doi.org/10.1002/cpt.3086">doi: 10.1002/cpt.3086&lt;/a>&lt;/p>
&lt;p>Brian O&amp;rsquo;Sullivan 1, Song Ounpraseuth 2, Laura James 2, Marc Majure 3, Jason Lang 4, Zhuopei Hu 2, Alan Simon 5, Scott Bickel 6, Brian Ely 7, L E Faricy 8, Maryam Garza 2, Melody Greer 2, Daniel Hsia 9, Akilah Jefferson 2, Lisa Knight 10, Jeannette Lee 2, Deborah Liptzin 11, Mehtap Haktanir Abul 12, Tamara T Perry 2, Fred Prior 2, Christine SanGiovanni 13, Jade Tam-Williams 14, Brian Wu 15, Jessica Snowden 2; ECHO IDeA States Pediatric Clinical Trial Network&lt;/p></description></item><item><title>France has injected 200,000 infants with RSV vaccine, based on no long-term data - Here we go again</title><link>//localhost:1313/posts/france-has-injected-200000-infants-with-rsv-vaccine-based-on-no-long-term-data-here-we-go-again.html</link><pubDate>Wed, 27 Dec 2023 00:00:00 +0000</pubDate><guid>//localhost:1313/posts/france-has-injected-200000-infants-with-rsv-vaccine-based-on-no-long-term-data-here-we-go-again.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#breaking---infant-mortality-concern-emerges-with-nirsevimab-rsv-monoclonal-antibody-given-to-newborns----dec-2023">BREAKING - Infant Mortality Concern Emerges with Nirsevimab RSV Monoclonal Antibody Given to Newborns - Dec 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#french-researchers-identify-improbably-high-rate-of-deaths-in-newborns-who-received-new-rsv-shot---jan-2024">French Researchers Identify ‘Improbably High Rate of Deaths’ in Newborns Who Received New RSV Shot - Jan 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rsv-vaccine-statistics">RSV VACCINE STATISTICS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rsv-vaccine-mostly-useless-and-costs-600httpswwwairfinitycomarticlesastrazenecas-infant-rsv-drug-beyfortus-could-generate-usd1-1bn-sales-revenue--absolute-risk-reduction--026----may-2023httpswwwtrialsitenewscomafda-approves-respiratory-syncytial-virus-vaccine-with-mostly-useless-026-absolute-risk-reduction-1638272d">RSV vaccine mostly useless and &lt;a href="https://www.airfinity.com/articles/astrazenecas-infant-rsv-drug-beyfortus-could-generate-usd1-1bn-sales-revenue">costs $600&lt;/a>, &lt;a href="https://www.trialsitenews.com/a/fda-approves-respiratory-syncytial-virus-vaccine-with-mostly-useless-0.26-absolute-risk-reduction-1638272d">Absolute Risk Reduction = 0.26% - May 2023&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="breaking---infant-mortality-concern-emerges-with-nirsevimab-rsv-monoclonal-antibody-given-to-newborns----dec-2023">BREAKING - Infant Mortality Concern Emerges with Nirsevimab RSV Monoclonal Antibody Given to Newborns - Dec 2023&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://petermcculloughmd.substack.com/p/breaking-infant-mortality-concern?utm_campaign=email-post&amp;amp;r=ofo3r&amp;amp;utm_source=substack&amp;amp;utm_medium=email">Dr. McCullough Substack&lt;/a>&lt;/strong>&lt;/p></description></item></channel></rss>